Moreover, SA-4-1BBL evoked strong anti-tumor effects when given as a vaccine adjuvant in the murine TC-1 HPV-driven tumor model (135–137), or in a Survivin+ lung carcinoma model (136, 138). The gene discussed is BIRC5; the disease is neoplasm.